Physician profile
Michael Walker Kelly
NPI 1013956150
$1,368.79
in general payments reported to CMS, 2019-2025
13 companies · $89.34 in 2025
The $89.34 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $37.91 · 2021: $27.94 · 2022: $279 · 2023: $353 · 2024: $99.71 · 2025: $89.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $619.58 | 2019-2023 | Tecnis Iol |
| Alcon Vision LLC | $176.57 | 2020-2025 | Clareon, Argos |
| Lensar, INC. | $108.47 | 2023 | Lensar Laser System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $92.35 | 2019 | |
| Bausch & Lomb Americas INC. | $83.46 | 2022-2024 | Envista Envy, Ic-8 Apthera Iol |
| Novartis Pharmaceuticals Corporation | $77.03 | 2022-2023 | |
| Glaukos Corporation | $54.07 | 2019-2025 | Kxl System (Not Refurbished) |
| Rxsight INC | $52.37 | 2023-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Biotissue Holdings INC. | $34.62 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $24.20 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Eyevance Pharmaceuticals LLC | $14.60 | 2022 | |
| Kala Pharmaceuticals, INC. | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.